Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: The need for randomized trials

Research output: Contribution to journalComment/debate

21 Scopus citations

Abstract

Vitamin D has been used in the context of secondary hyperparathyroidism in patients with end-stage renal disease. A wave of recent studies suggests that vitamin D treatment may be associated with decreased mortality risk in these patients. The article by Wolf et al. further supports these studies by identifying vitamin D deficiency as a risk factor for early mortality in incident hemodialysis patients.

Original languageEnglish
Pages (from-to)909-911
Number of pages3
JournalKidney International
Volume72
Issue number8
DOIs
StatePublished - Oct 2007
Externally publishedYes

Fingerprint Dive into the research topics of 'Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: The need for randomized trials'. Together they form a unique fingerprint.

  • Cite this